glp-1 colorectal cancer death risk study november 2025 Emerging Evidence Positions Receptor Agonists as a Novel Strategy to Reduce CRC GLP-1 use linked to better

No product was tested by this publication, and no clinical claim made by the brand was independently verified beyond confirming that the brand itself makes the claim

This treatment helps to ensure that the body gets the nutrients it needs to function at its best

1: Seim H, Eichler K, Kleber H (2001)

Oral semaglutide risks: The pill version of semaglutide, Rybelsus and Ozempic, contains an absorption enhancer called SNAC that helps the medication survive the stomach

10.1523/JNEUROSCI.2916-12.2013 J

Um, and if we, if were just giving it away because were going on a drastic weight loss diet, thats, you know, were, were quite literally aging our body 10 years